Bradley L. Radoff - Aug 26, 2024 Form 4 Insider Report for Guardion Health Sciences, Inc. (GHSI)

Role
10%+ Owner
Signature
/s/ Bradley L. Radoff
Stock symbol
GHSI
Transactions as of
Aug 26, 2024
Transactions value $
-$1,626,419
Form type
4
Date filed
8/28/2024, 04:11 PM
Previous filing
Aug 19, 2024
Next filing
Sep 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GHSI Common Stock Sale -$713K -52.7K -24.18% $13.54 165K Aug 26, 2024 Direct F1, F2
transaction GHSI Common Stock Sale -$644K -44.6K -26.97% $14.46 121K Aug 26, 2024 Direct F1, F3
transaction GHSI Common Stock Sale -$130K -8.25K -6.84% $15.77 112K Aug 26, 2024 Direct F1
transaction GHSI Common Stock Sale -$139K -10.1K -40.06% $13.80 15K Aug 26, 2024 By The Radoff Family Foundation F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bradley L. Radoff is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.